FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.10  |  FHIR Version n/a  User: [n/a]

22263211000001108: Elvanse 30mg capsules (Takeda UK Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2013. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
1801301000001112 Elvanse 30mg capsules (Takeda UK Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
1801321000001117 Elvanse 30mg capsules (Takeda UK Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Elvanse 30mg capsules (Takeda UK Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category Schedule 2 (CD) true Inferred relationship Existential restriction modifier
Elvanse 30mg capsules (Takeda UK Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
Elvanse 30mg capsules (Takeda UK Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Elvanse 30mg capsules (Takeda UK Ltd) Is a Product containing precisely lisdexamfetamine dimesylate 30 milligram/1 each conventional release oral capsule true Inferred relationship Existential restriction modifier
Elvanse 30mg capsules (Takeda UK Ltd) Has active ingredient Lisdexamfetamine dimesylate false Inferred relationship Existential restriction modifier
Elvanse 30mg capsules (Takeda UK Ltd) Has manufactured dose form Conventional release oral capsule true Inferred relationship Existential restriction modifier
Elvanse 30mg capsules (Takeda UK Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Elvanse 30mg capsules (Takeda UK Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Elvanse 30mg capsules (Takeda UK Ltd) Has specific active ingredient Lisdexamfetamine dimesylate true Inferred relationship Existential restriction modifier
Elvanse 30mg capsules (Takeda UK Ltd) Has dispensed dose form Capsule true Inferred relationship Existential restriction modifier
Elvanse 30mg capsules (Takeda UK Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Elvanse 30mg capsules (Takeda UK Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Elvanse 30mg capsules (Takeda UK Ltd) Is a Elvanse true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Elvanse 30mg capsules (Takeda UK Ltd) 28 capsule Has AMP True Elvanse 30mg capsules (Takeda UK Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start